Product

RealStar ASR Trichomonas vaginalis

Product

UC-TIB-HPV-GT (HPV31/33/45/52/58)

UC-TIB-HPV-GT (HPV31/33/45/52/58) is a nucleic acid test from Roche Diagnostics, listed for HPV. Registration status and availability vary by market.

Product

VitaSIRO solo™ HPV Assay

VitaSIRO solo™ HPV Assay is catalogued from public product materials published by Credo Diagnostics. Availability: not published on this record. Regulatory status is manufacturer-reported and has not been independently verified. Confirm intended use, compatibility and local registration against official documentation before procurement.

Article

Advances in isothermal nucleic acid amplification-based HPV assays for cervical cancer screening in low- and middle-income countries: A scoping review.

Research record from Cancer Epidemiol, 2026-10-06. PMID 42837910.

Platform Page

Clinical Topics | IVD Industry Hub

Navigate IVD content by respiratory, HPV, STI, gastrointestinal, bloodborne, and outbreak-response topics.

Article

Comparison of Colorimetric LAMP and PCR for High-risk HPV Detection: Implications for Cervical Cancer Screening.

Research record from J Low Genit Tract Dis, 2026-10-01. PMID 42565594.

Article

Comparison of mRNA-based and next-generation sequencing HPV assays in a population-based cervical cancer screening program in China.

Research record from J Gynecol Oncol, 2026-05-18. PMID 42172491.

Article

Diagnostic utility of HPV-16/18 E6 mRNA fold change measured by in-house semi-quantitative real-time PCR in cervical cancer triage for differentiation of CIN3 and cervical cancer from lower-grade lesions.

Research record from Diagn Microbiol Infect Dis, 2026-09-20. PMID 42801821.

Tests

GP5+/GP6+ PCR Assay

A PCR technique that uses the GP5+/GP6+ primer set for HPV detection. It amplifies a 150 bp region from the L1 region of the HPV genome.

Indicators

High-risk HPV

Group of HPV genotypes associated with higher risk of cervical disease.

Glossary Term

High-risk HPV Types

Placeholder definition before migration.

Article

HPV screening tenders: what to verify beyond the CE mark

What procurement teams should verify in HPV screening tenders: analytical performance floors, genotyping granularity, clinical evidence grading, and programme integration.